Harlow, United Kingdom

Julie A Abrahamson

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Johns Hopkins University, Smithkline Beecham Corporation. Active years: 2009-2012.


% Patents Active = 25.0


Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Julie A Abrahamson

Introduction

Julie A Abrahamson is a notable inventor based in Harlow, GB. She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of 4 patents to her name, her work has implications for both diagnostics and therapeutics.

Latest Patents

Among her latest patents are the "Sialoadhesin factor-2 antibodies," which describe monoclonal antibodies that bind to human sialoadhesion factor-2. These antibodies are recognized for their utility as diagnostic and therapeutic reagents. Additionally, she has developed methods of use for these antibodies, further emphasizing their importance in medical applications.

Career Highlights

Julie has had a distinguished career, working with prestigious institutions such as The Johns Hopkins University and SmithKline Beecham Corporation. Her research has been pivotal in advancing our understanding of sialoadhesin factors and their applications in medicine.

Collaborations

Throughout her career, Julie has collaborated with esteemed colleagues, including Connie L Erickson-Miller and Kristine Kay Kikly. These partnerships have enriched her research and contributed to her innovative work.

Conclusion

Julie A Abrahamson's contributions to the field of biomedical research through her patents and collaborations highlight her as a significant figure in innovation. Her work continues to impact the development of diagnostic and therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…